<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1975">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04473157</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU P45a/2020</org_study_id>
    <nct_id>NCT04473157</nct_id>
  </id_info>
  <brief_title>COVID-19 in Patients With Anosmia in Egypt</brief_title>
  <official_title>Detection of SARS-CoV-2 in Patients Presenting With Anosmia During COVID-19 Pandemic Era in Egypt</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to test the frequency of severe acute respiratory syndrome new corona virus
      SARS-CoV-2 or other respiratory viruses in patients presenting with anosmia or dysgeusia to
      Ain Shams University Hospitals, Cairo, Egypt.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fifty Patients presenting to Triage and/or Ear, Nose and Throat (ENT) clinics in Ain Shams
      University Hospitals with the chief complaint of Anosmia/ dysgeusia in the period July-
      September 2020; will undergo thorough history taking, clinical assessment and polymers chain
      reaction rt-PCR to SARS-COV2; and if proven negative to COVID 19, PCR to other respiratory
      pathogens will be tested. COVID-19 patients will be managed according to the standard
      protocol of Ain Shams University Hospitals. Follow up after 3 weeks for the outcome of
      recovery of the smell sense and seroconversion by rapid test for immunoglobulins IgM/ IgG of
      COVID 19, for the probability of a false negative PCR at initial visit.

      Ethical committee approval for the current study protocol was obtained. Patients will be
      invited to participate and the informed consent will be signed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">October 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Recovery from Anosmia</measure>
    <time_frame>3 weeks</time_frame>
    <description>subjective questionnaire about smell and taste</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Seroconversion</measure>
    <time_frame>3 weeks</time_frame>
    <description>developing IgM/ IgG antibodies by rapid test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>COVID 19</measure>
    <time_frame>3 weeks</time_frame>
    <description>developing other symptoms of COVID 19</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Anosmia</condition>
  <condition>Covid19</condition>
  <condition>Dysgeusia</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Nasopharyngeal and oropharyngeal Swabs
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Fifty Patients presenting to Triage and/or ENT clinics in Ain Shams University Hospitals
        with the chief complaint of Anosmia/ dysgeusia in the period July- August 2020
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult (&gt;18 years) patients presented with acute-onset anosmia.

        Exclusion Criteria:

          -  patients with anosmia or gustatory dysfunctions before the epidemic; patients with
             previous history of chronic sinusitis or previous sinus surgery.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ossama I Mansour, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ossama I Mansour, MD</last_name>
    <phone>(202) 24346042</phone>
    <email>mansouroi@med.asu.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ossama I Mansour, MD</last_name>
      <phone>(202) 24346042</phone>
      <email>mansouroi@med.asu.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <link>
    <url>https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html</url>
    <description>Symptoms of coronavirus. US Centers for Disease Control and Prevention website.</description>
  </link>
  <reference>
    <citation>Moein ST, Hashemian SM, Mansourafshar B, Khorram-Tousi A, Tabarsi P, Doty RL. Smell dysfunction: a biomarker for COVID-19. Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950. doi: 10.1002/alr.22587. Epub 2020 Jun 18.</citation>
    <PMID>32301284</PMID>
  </reference>
  <reference>
    <citation>Spinato G, Fabbris C, Polesel J, Cazzador D, Borsetto D, Hopkins C, Boscolo-Rizzo P. Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. JAMA. 2020 May 26;323(20):2089-2090. doi: 10.1001/jama.2020.6771.</citation>
    <PMID>32320008</PMID>
  </reference>
  <reference>
    <citation>Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA, Ganesh S, Varsavsky T, Cardoso MJ, El-Sayed Moustafa JS, Visconti A, Hysi P, Bowyer RCE, Mangino M, Falchi M, Wolf J, Ourselin S, Chan AT, Steves CJ, Spector TD. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020 Jul;26(7):1037-1040. doi: 10.1038/s41591-020-0916-2. Epub 2020 May 11.</citation>
    <PMID>32393804</PMID>
  </reference>
  <reference>
    <citation>Desforges M, Le Coupanec A, Brison E, Meessen-Pinard M, Talbot PJ. Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans. Adv Exp Med Biol. 2014;807:75-96. doi: 10.1007/978-81-322-1777-0_6. Review.</citation>
    <PMID>24619619</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 15, 2020</study_first_submitted>
  <study_first_submitted_qc>July 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 16, 2020</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 17, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Ossama Mansour, MD, FACS</investigator_full_name>
    <investigator_title>Professor of Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>Corona virus</keyword>
  <keyword>SARS-CoV-2</keyword>
  <keyword>Olfactory Disturbance</keyword>
  <keyword>Taste Disturbance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Olfaction Disorders</mesh_term>
    <mesh_term>Dysgeusia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

